Efficacy of albendazole against Giardia and hookworm in a remote Aboriginal community in the north of Western Australia

Acta Tropica

Volumn 71, Issue 1, 1998, Pages 27-44

  Reynoldson, J A ^a   Behnke, J M ^c   Gracey, M ^d   Horton, R J ^b   Spargo, R ^d   Hopkins, R M ^a   Constantine, C C ^a   Gilbert, F ^c   Stead, C ^b   Hobbs, R P ^a   Thompson, R C A ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d NONE

Author keywords

Acylostoma duodenale; Albendazole; Giardia duodenalis; Hookworm

Indexed keywords

ALBENDAZOLE;

INDIGENOUS POPULATION; INFECTIOUS DISEASE; PARASITE CONTROL;

ABDOMINAL PAIN; ABORIGINE; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; GIARDIASIS; HOOKWORM INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALBENDAZOLE; ANCYLOSTOMA; ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GIARDIA; GIARDIASIS; HOOKWORM INFECTIONS; HUMANS; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; PARASITE EGG COUNT; PREVALENCE; SEX FACTORS; STATISTICS, NONPARAMETRIC; WESTERN AUSTRALIA;

AUSTRALIA, WESTERN AUSTRALIA;

ANCYLOSTOMATOIDEA; GIARDIA; GIARDIA INTESTINALIS;

EID: 17644444373     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(98)00048-5     Document Type: Article

References (44)

1. Albonico M., Smith P.G., Hall A., Chwaya H. M., Alawi K.S., Savioli L. A randomised controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans. Roy. Soc. Trop. Med. Hyg. 88:1994;585-589.
2. Al-Waili N.S. Mebendazole in Trichomonas hominis. Clin. Exp. Pharmacol. Physiol. 14:1987;679-680.
3. Al-Waili N.S. Mebendazole in Giardia infections: in-appropriate doses. Trans. Roy. Soc. Trop. Med. Hyg. 84:1990;753-754.
4. Al-Waili N.S., Al-Waili B.H., Saloom K.Y. Therapeutic use of mebendazole in giardial infections. Trans. Roy. Soc. Trop. Med. Hyg. 82:1988;438.
5. Anderson R.M. The population dynamics and epidemiology of intestinal nematode infections. Trans. Roy. Soc. Trop. Med. Hyg. 80:1986;686-696.
6. Beaver P.C., Jung R.C., Cupp E.W. Clinical Parasitology. 9th:1984;825 Lea and Febiger, Philadelphia.
7. Behnke JM, Pritchard DI, Wakelin D, Park JR, McNicholas AM, Gilbert FS Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone. J. Helminth. 68:1994;187-195.
8. Botero D. Nematode infections of man: Intestinal infections. Campbell W.C., Rew R.S. Chemotherapy of Parasitic Diseases. 1986;Plenum, New York.
9. Bradley M., Chandiwana S.K., Bundy D.A.P., Medley G.F. The epidemiology and population biology of Necator americanus infection in a rural community in Zimbabwe. Trans. Roy. Soc. Trop. Med. Hyg. 86:1992;73-76.
10. Cheng-i W. Parasitic diarrhoeas in China. Parasitol. Today. 4:1988;284-286.
11. Coles G.C. Chemotherapy of human nematodes: learning from the problems in sheep. J. Roy. Soc. Med. 88:1995;649P-651.
12. Coulaud J.P., Deluol A.M., Cenac J., Rossignol J.F. L'albendazole dans le traitement de la strongyloidose: a propos de 66 observations. Bull Soc Pathol. Exot. Fil. 75:1982;530-533.
13. Crawley MT GLIM for Ecologists. 1993;Blackwell Scientific, Oxford.
14. De Clercq D., Sacko M., Behnke J.M., Gilbert F., Dorny P., Vercruysse J. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali, West Africa. Am. J. Trop. Med. Hyg. 57:1997;25-30.
15. Gascon J., Moreno A., Vallis M.E., Miro J.M. Failure of mebendazole treatment in Giardia lamblia infection. Trans. Roy. Soc. Trop. Med. Hyg. 83:1989;647.
16. Hall A., Anwar K.S. Albendazole and infections with Trichuris and Giardia intestinalis. Southeast Asian J. Trop. Med. Publ. Health. 22:1991;84-87.
17. Hall A., Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans. Roy. Soc. Trop. Med. Hyg. 87:1993;84-86.
18. Haswell-Elkins M.R., Elkins D.B., Manjula K., Michael E., Anderson R.M. An investigation of hookworm infection and reinfection following mass anthelmintic treatment in the South Indian fishing community of Vairavankuppam. Parasitology. 96:1988;565-577.
19. Hopkins R.M., Deplazes P., Meloni B.P., Reynoldson J.A., Thompson R.C.A. A field and laboratory evaluation of a commercial ELISA for the detection of Giardia copro-antigens in humans and dogs. Trans. Roy. Soc. Trop. Med. Hyg. 87:1992;39-41.
20. Hopkins R.M., Gracey M., Hobbs R.P., Spargo R.M., Yates M., Thompson R.C.A. The prevalence of hookworm infection, iron deficiency and anaemia in an Aboriginal community in north-west Australia. Med. J. Aust. 166:1997;241-244.
21. Hopkins R.M., Meloni B.P., Groth D.M., Wetherall J.D., Reynoldson J.A., Thompson R.C.A. Ribosomal RNA sequencing reveals differences between the genotypes of Giardia isolates recovered from humans and dogs living in the same locality. J. Parasitol. 83:1997;44-51.
22. Horton R.J. The use of antiprotozoan and anthelmintic drugs during pregnancy. J. Infect. 26:1993;104-105.
23. Horton R.J. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Tropica. 64:1997;79-93.
24. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Revt. Inst. Med. Trop. S. Paolo. 14:1972;397-400.
25. Maisonneuve H., Rossignol J.F., Addo A., Mojon M. Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis. Ann. Trop. Med. Parasitol. 79:1985;79-82.
26. Mani G.G., Tata Rao S., Madhavi R. Estimation of hookworm intensity by anthelmintic expulsion in primary schoolchildren in South India. Trans. Roy. Soc. Trop. Med. Hyg. 87:1993;634-635.
27. Meloni B.P., Thompson R.C.A., Reynoldson J.A., Seville P. Albendazole: A more effective antigiardial agent in vitro than metronidazole or tinidazole. Trans. Roy. Soc. Trop. Med. Hyg. 84:1990;375-379.
28. Meloni B.P., Lymbery A.J., Thompson R.C.A. Genetic characterisation of isolates of Giardia duodenalis by enzyme electrophoresis: implications for reproductive biology population structure, taxonomy and epidemiology. J. Parasitol. 81:1995;368-383.
29. Pamba H.O., Bwibo N.O., Chunge C.N., Estambale B.B.A. A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helminthiasis in Kenyan children less than 2 years of age. East Afr. Med. J. 66:1989;197-202.
30. Pene P., Mojon M., Coulaud J.P., Rossignol J.F. Albendazole: a new broad spectrum anthelmintic. Double-blind multicenter clinical trial. Am. J. Trop. Med. Hyg. 31:1982;263-266.
31. Prociv P., Luke R.A. The changing epidemiology of human hookworm infection in Australia. Med. J. Aust. 162:1995;150-154.
32. Prociv P., Luke R.A. Evidence for larval hypobiosis in Australian strains of Ancylostoma duodenale. Trans. Roy. Soc. Trop. Med. Hyg. 89:1995;379.
33. Raccurt C.P., Lambert M.-T., Bouloumie J., Ripert C. Evaluation of the treatment of intestinal helminthiases with albendazole in Djohong (North Cameroon). Trop. Med. Parasitol. 41:1990;46-48.
34. Ramalingham S., Sinniah B., Krishnan U. Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am. J. Trop. Med. Hyg. 32:1983;984-989.
35. Reynoldson J.A., Behnke J.M., Pallant L.J., Macnish M.G., Gilbert F., Thompson R.C.A. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Tropica. 68:1997;301-312.
36. Reynoldson J.A., Thompson R.C.A., Horton R.J. Albendazole as a future antigiardial agent. Parasitol. Today. 8:1992;412-413.
37. Reynoldson J.A., Thompson R.C.A., Meloni B.P. In vivo efficacy of albendazole against Giardia duodenalis in mice. Parasitol. Res. 77:1991;325-328.
38. Roberts D., Gracey M., Spargo R.M. Growth and morbidity in children in a remote Aboriginal community in north-west Australia. Med. J. Aust. 148:1988;68-71.
39. Rossignol J.F., Coulaud J.P. Summary of clinical trials worldwide (evaluation of albendazole in Europe, West Africa and Asia as a single dose anthelmintic: report on 1455 patients), Albendazole in Helminthiasis. .Firth M. International Congress Symposium Series. 1983;19-27 Royal Society of Medicine, London.
40. Schad G.A., Nawalinski T.A., Kochar V. Human ecology and the distribution and abundance of hookworm populations. Croll N.A., Cross J.H. Human Ecology and Infectious Diseases. 1983;187-224 Academic Press, New York.
41. Stephenson L.S., Latham M.C., Adams E.J., Kinoti S.N., Pertet A. Physical fitness, growth and appetite of Kenyan schoolboys with hookworm, Trichuris trichiura, and Ascaris lumbricoides infections are improved four months after a single dose of albendazole. J. Nutr. 123:1993;1036-1046.
42. Stephenson L.S., Latham M.C., Adams E.J., Kinoti S.N., Pertet A. Weight gain of Kenyan school children infected with hookworm, Trichuris trichiura, and Ascaris lumbricoides is improved following once- or twice-yearly treatment with albendazole. J. Nutr. 123:1993;656-665.
43. World Health Organisation, 1961. CCTA/WHO African conference on ancylostomiasis, Brazzaville, 22-29 August. Tech. Rep. Ser. 1963; No. 225.
44. Zhong H-L., Cao W-J., Rossignol J.F., Feng M-L., Hu R-Y., Gan S-B., Tan W. Albendazole in nematode, cestode, trematode and protozoan (Giardia) infections. Chin. Med. J. 99:1986;912-915.